可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 赵艳芳, 秦永文, 李建国. 曲美他嗪对实验性心肌缺血的保护作用 [J] . 第二军医大学学报, 2001, 22:868-870.
[2] Kantor PF, Lucien A, Kozak R, et al. Metabolic mechanisms associated with antianginal therapy [J] . Circulation Research, 2000, 86:487.
[3] Szwed H. 糖尿病患者冠心病的代谢治疗 [J] . Heart and Metabolish, 2001, 11(2):26-29.
[4] Szwed H, Sadowski Z, Pachocki R, et al. The anti ischemic effects and toler ability of trimetazidine in coronary diabetic patients. A substudy from TRIMPOL-I [J] . Cardiovasc Drugs Ther, 1999, 13:217-222.
[5] 中国曲美他嗪多中心临床研究协作组. 曲美他嗪对稳定性心绞痛的疗效观察 [J] . 中华心血管病杂志, 2000, 28:5.
[6] Lu C, Dabrowski P, Fragasso G, et al. Effects of Trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease [J] . Am J Cardiol, 1998, 82:898-901.
[7] Steg PG, Laperche T, Karila-Cohen D. Value of trimetazidine as adjuvant therapy for primary PTCA at the stage of myocardial infarction [J] . Eur Heart J, 1999, (supplo):o19-o23.
[8] Tunerir B, Colak O, Alatas O, et al. Measurement of troponin T to detect cardioprotective effect of Trimetazidine during coronary artery bypass grafting [J] . Am Thouac Surg, 1999, 68:2173-2176.
[9] 李泽林, 殷长宁. 曲美他嗪对不稳定型心绞痛QT间期离散度影响 [J] . 中国综合临床, 2002, 18:36.
[10] 林钟文, 吴盛标, 吴胜楠, 等. 曲美他嗪治疗冠心病伴糖尿病的疗效观察 [J] . 临床心血管杂志, 2001, 17:66.
[11] 覃振文, 肖俊杰, 杨向阳. 曲美他嗪对无症状性心肌缺血的影响 [J] . 实用医学杂志, 2001, 17:1083.